Important notice for companies : We would like to inform companies interested in participating in government tenders that it is a requirement for the company to be classified. Additionally, we would like to note that the linking of tender financial ceilings to a company’s financial limits—for the suppliers and service providers sector—has been postponed until the end of this year. This aims to give more companies the opportunity to fulfill their enhanced classification requirements.

Tender & its Companies' Details

Tender type Direct Agreement Requested Sector Type Suppliers / Service Providers
Ministry Hamad Medical Corporation Tender number 5357/2025
Tender subject SUPPLY OF DRUGS (FAPREMILAST 30MG TAB, APREMILAST STARTER PACK ( 4TAB 10 MG + 4 TAB 20 MG + 19 TAB 30 MG ), DARBEPOETIN ALFA 10 MCG,DARBEPOETIN ALFA 100 MCG, DARBEPOETIN ALFA 40 MCG, DARBEPOETIN ALFA 60 MCG,ETELCALCETIDE INJ 5 MG/1 ML,EVOLOCUMAB 140 MG INJ)-HMC/TCS/3963189/2025
Tender Number at Ministry Publish date
Envelopes system Two Envelopes Closing Date
Document Value (QAR) Tender Bond (QAR)
Technical Opening Date Financial Open Date 22/09/2025
Awarded Date 22/09/2025 Awarded Amount (QAR) 32,023,846.80

Awarded companies data

Company name Commercial Registration Number Approved Value Financial Result Approved Items
DOHA DRUG STORE 14993 | 9039 32,023,846.80 QAR

Technically opened companies data

Company name Commercial Registration Number
DOHA DRUG STORE 14993 | 9039

Financially opened companies data

Company name Commercial Registration Number Proposal amount Local Value Ratio Financial Result Notes
DOHA DRUG STORE 14993 | 9039 32,023,846.80 QAR 13.29